ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancer? early trial combines two drugs
Disease control Recruiting nowThis early-stage trial tests a new drug called SHR-2524 combined with bevacizumab in 36 people with advanced liver cancer that hasn't been treated before. The main goals are to check safety, how the body processes the drugs, and to get an early look at whether the combination mig…
Matched conditions: ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New immunotherapy cocktail takes on tough liver tumors
Disease control Recruiting nowThis Phase 2 trial tests whether adding an experimental drug called RBS2418 to a standard immunotherapy regimen (tremelimumab plus durvalumab) can better control advanced liver cancer that cannot be removed by surgery. About 220 adults will receive either the combination or the s…
Matched conditions: ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC